Efficacy and Safety Study of Cyclosporine 0.010% to Treat Atopic Keratoconjunctivitis

NCT00884585 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

176

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Conjunctivitis

Interventions

DRUG: Cyclosporine Vehicle
DRUG: Cyclosporine 0.010%

Sponsor

Allergan